Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00850135 · ClinicalTrials.gov registry record · Phase 1
Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 57
- Enrollment target
NCT00850135: Completed Phase 1 study, sponsored by Stanford University.
NCT00850135 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00850135, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 57 participants
- Enrollment target
Study Summary
Diabetic pregnant patients are at risk for adverse pregnancy outcomes, including larger than expected fetuses and unplanned operative deliveries, due to elevated blood glucose levels. the one-hour glucola test is currently used to screen pregnant patients for gestational diabetes. This involves ingesting a 50-gram glucose load, followed by a blood test one hour later. We wish to compare 7-day continuous glucose monitoring to the one-hour glucola test, and determine which one correlates better with adverse pregnancy outcomes as well as which one more accurately identifies patients at risk for adverse pregnancy outcomes.
Interventions
- DEVICE The Seven Continuous Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2009-02 |
| Est. Completion | 2015-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00850135
The ClinicalTrials.gov registry entry for NCT00850135 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The Seven Continuous Glucose Monitoring System is the first listed.
NCT00850135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00850135 about?
NCT00850135 is a clinical study titled "Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes". Diabetic pregnant patients are at risk for adverse pregnancy outcomes, including larger than expected fetuses and unplanned operative deliveries, due to elevated blood glucose levels. the one-hour glucola test is currently used to screen pregnant patients for gestational diabetes. This involves inge...
What is the current status of trial NCT00850135?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 57 participants. The study started on 2009-02. Estimated completion is 2015-09.
What interventions are being tested in trial NCT00850135?
The interventions under investigation include: The Seven Continuous Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT00850135?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.